Alive | Liver related deaths | Other deaths | Total | ||||||
Total | 223 (100) | 26 (100) | 61 (100) | 310 (100) | |||||
Coagulation disorder | |||||||||
Haemophilia A | 147 (66) | 22 (85) | 58 (95) | 227 (73) | |||||
Haemophilia B | 44 (20) | 3 (12) | 2 (3) | 49 (16) | |||||
VWD | 23 (10) | 1 (4) | 1 (2) | 25 (8) | |||||
Other | 9 (4) | 9 (3) | |||||||
Age (y) at HCV infection | |||||||||
Median | 15.3 | 27.2 | 23.3 | 17.4 | |||||
Range | (0.01–61.3) | (6.8–62.8) | (2.0–76.8) | (0.01–76.8) | |||||
HIV | |||||||||
HIV positive | 54 (24) | 20 (77) | 51 (84) | 125 (40) | |||||
HCV genotype | |||||||||
Total tested | 159 (71) | (100) | 22 (85) | (100) | 32 (52) | (100) | 213 (67) | (100) | |
1 | 94 | (59) | 19 | (86) | 22 | (69) | 135 | (63) | |
2 | 23 | (15) | 3 | (14) | 3 | (9) | 29 | (14) | |
3 | 34 | (21) | 5 | (16) | 39 | (18) | |||
4 | 2 | (1) | 2 | (6) | 4 | (2) | |||
5 | 2 | (1) | 2 | (1) | |||||
Mixed | 4 | (3) | 4 | (2) | |||||
HCV viraemia | |||||||||
Total tested | 189 (83) | (100) | 7 (27) | (100) | 4 (7) | (100) | 200 (65) | (100) | |
Positive | 133 | (70) | 7 | (100) | 3 | (75) | 143 | (72) | |
Last measured HCV viral load×106 genome eq/ml | |||||||||
Total tested | 150 (67) | 7 (27) | 3 (5) | 160 (49) | |||||
Median | 8.1 | 19.1 | 8 | 8.3 | |||||
Range | (<0.2–126) | (1.3–41.4) | (1.3–16) | (<0.2–126) |
Total cohort ( ) percentage; subpopulation( ) percentage.
VWD, von Willebrand's disease.